Tokyo - Delayed Quote JPY

CUC Inc. (9158.T)

1,039.00
+11.00
+(1.07%)
At close: 3:30:00 PM GMT+9
Loading Chart for 9158.T
  • Previous Close 1,028.00
  • Open 1,023.00
  • Bid 1,039.00 x --
  • Ask 1,042.00 x --
  • Day's Range 1,023.00 - 1,050.00
  • 52 Week Range 970.00 - 2,061.00
  • Volume 107,300
  • Avg. Volume 208,116
  • Market Cap (intraday) 30.459B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 9.73
  • EPS (TTM) 106.81
  • Earnings Date Apr 28, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 1,400.00

CUC Inc. offers healthcare services in Japan, Asia and internationally. It provides hospital care, dialysis care, visiting nurses, and home hospices services, as well as management support services for healthcare institutions; and healthcare consulting services. The company was founded in 2014 and is based in Minato-Ku, Japan. CUC Inc. operates as a subsidiary of M3 Inc.

www.cuc-jpn.com

--

Full Time Employees

March 31

Fiscal Year Ends

Recent News: 9158.T

View More

Performance Overview: 9158.T

Trailing total returns as of 6/3/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

9158.T
40.18%
Nikkei 225 (^N225)
6.14%

1-Year Return

9158.T
31.55%
Nikkei 225 (^N225)
3.79%

3-Year Return

9158.T
76.55%
Nikkei 225 (^N225)
34.89%

5-Year Return

9158.T
76.55%
Nikkei 225 (^N225)
65.59%

Compare To: 9158.T

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 9158.T

View More

Valuation Measures

Annual
As of 6/2/2025
  • Market Cap

    30.14B

  • Enterprise Value

    66.05B

  • Trailing P/E

    9.62

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.64

  • Price/Book (mrq)

    1.02

  • Enterprise Value/Revenue

    1.40

  • Enterprise Value/EBITDA

    7.30

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.66%

  • Return on Assets (ttm)

    4.51%

  • Return on Equity (ttm)

    10.56%

  • Revenue (ttm)

    47.04B

  • Net Income Avi to Common (ttm)

    3.13B

  • Diluted EPS (ttm)

    106.81

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    7.53B

  • Total Debt/Equity (mrq)

    143.78%

  • Levered Free Cash Flow (ttm)

    -240M

Research Analysis: 9158.T

View More

Company Insights: 9158.T

Research Reports: 9158.T

View More

People Also Watch